Enhanced external counterpulsation (EECP) is a noninvasive treatment that uses inflatable pressure cuffs wrapped around your legs to improve blood flow to the heart. It’s FDA-approved for chronic angina (chest pain from coronary artery disease) and heart failure, and it’s designed for people who haven’t gotten enough relief from medications or who aren’t candidates for surgery. A standard course involves 35 one-hour sessions spread over seven weeks.
How EECP Works
During each session, you lie on a padded treatment bed while large blood pressure-style cuffs are strapped around your calves, thighs, and buttocks. These cuffs inflate and deflate in rhythm with your heartbeat, timed by continuous electrocardiogram monitoring. The inflation happens during diastole, the moment between heartbeats when your heart is relaxing and filling with blood. That squeeze pushes blood from your legs back up toward your heart and into the coronary arteries, boosting blood supply to the heart muscle when it needs it most.
Then, just before your heart contracts again to pump blood out, all three cuffs deflate simultaneously. This sudden release of pressure reduces the resistance your heart has to push against, effectively lowering its workload. The result is a kind of double benefit: more blood reaching the heart, with less effort required to pump it.
Beyond these immediate effects, the repeated surges of blood flow create something called shear stress on the inner walls of your blood vessels. This mechanical force stimulates the endothelium, the thin lining of your arteries, to function more normally. Over the course of treatment, it triggers the release of growth signals that encourage the formation of new small blood vessels around blocked or narrowed arteries. These natural bypasses, called collateral circulation, can improve blood flow to oxygen-starved areas of the heart long after treatment ends. Research published in Frontiers in Cardiovascular Medicine found that patients who completed EECP had significantly higher levels of these vascular growth signals compared to patients on medication alone, and the improvements in blood vessel function persisted at one-year follow-up.
What a Treatment Course Looks Like
The standard protocol is 35 sessions, each lasting one hour, scheduled Monday through Friday for seven weeks. You remain fully clothed during treatment, typically wearing a thin, form-fitting bodysuit under the cuffs to reduce friction. Most people describe the sensation as a firm rhythmic squeezing, similar to a blood pressure cuff cycling on and off. It’s not painful, though the pressure can feel unusual at first.
Because you’re lying down the entire time, many patients read, watch TV, or nap during sessions. There’s no recovery period afterward. You can drive yourself home and return to normal activities immediately. Some treatment centers offer twice-daily sessions to complete the course faster, though once daily is more common.
Who It Helps Most
EECP was developed primarily for people with chronic, stable angina who still have symptoms despite medication, and who either can’t undergo bypass surgery or stenting or have already had those procedures without adequate relief. Cardiologists sometimes call these “no-option” patients. It’s also used in certain cases of ischemic heart failure, where reduced blood flow has weakened the heart muscle.
Data from the International EECP Patient Registry, which tracked 363 patients with refractory angina, found that 77% experienced a measurable improvement in their angina severity. Of that group, 18% became completely free of chest pain after completing the full course. Among patients who improved, 55% maintained those benefits over longer-term follow-up, with some remaining symptom-free for up to two years. Patients also reported increased exercise tolerance and a longer window of physical activity before chest pain set in.
Benefits Beyond the Heart
Because EECP improves circulation broadly, not just to the heart, it also increases blood perfusion to the brain, kidneys, and other organs. This whole-body effect has generated interest in using it for conditions driven by poor circulation or blood vessel dysfunction.
The most notable recent application is for long COVID. A 2024 study in the American Journal of Cardiology followed 231 patients with persistent post-COVID symptoms including fatigue, shortness of breath, brain fog, and chest pain. After an average of about 33 EECP sessions, patients showed significant improvements across every measured outcome. Fatigue scores dropped substantially, walking distance on a six-minute test increased by an average of 152 feet, and 90% of patients who reported brain fog said their cognitive symptoms improved. Perhaps most strikingly, 78% of patients were able to return to work. No safety concerns were reported across more than 7,200 cumulative hours of treatment. This was a retrospective study without a control group, so the results are preliminary, but they point to a potential role for EECP in vascular-driven conditions beyond traditional heart disease.
Side Effects
EECP is considered very low-risk. The most common complaint is mild skin irritation from the pressure cuffs, similar to chafing. Bruising and pressure sores from the cuffs can occur but are rare. Some patients feel tired after their first few sessions as their body adjusts. There are no incisions, no anesthesia, and no needles involved, which is part of the appeal for patients who want to avoid invasive procedures.
Who Should Not Have EECP
Several conditions make EECP unsafe. The treatment relies on precisely timed inflation synchronized to your heartbeat, so uncontrolled irregular heart rhythms (like atrial fibrillation or frequent premature beats) can interfere with the system and are a contraindication. A resting heart rate below 35 or above 125 beats per minute also disqualifies you.
Because the cuffs apply significant pressure to your legs and abdomen, the following conditions rule out treatment:
- Blood clot risk: current or prior deep vein thrombosis, pulmonary embolism, or severe vein disease
- Severe peripheral artery disease: the compression could worsen already compromised leg circulation
- Abdominal aortic aneurysm or dissection: external pressure could be dangerous
- Recent surgery or catheterization: any surgical procedure within six weeks, or a cardiac catheterization within one to two weeks
- Bleeding disorders: conditions or medications causing significant blood thinning
Acute heart failure, a heart attack within the last three months, unstable angina, severe uncontrolled high blood pressure (above 180/110), moderate to severe aortic valve leakage, severe chronic lung disease, and pregnancy are also contraindications. Your cardiologist will screen for all of these before approving treatment.
Cost and Insurance Coverage
Medicare covers EECP for patients with severe angina who meet specific criteria, including documented coronary artery disease and inadequate response to other treatments. The covered course is 35 one-hour sessions. Many private insurers follow Medicare’s lead, though coverage policies vary. If you’re considering EECP, it’s worth calling your insurer before starting, since out-of-pocket costs for the full seven-week course can be significant without coverage. Treatment centers that specialize in EECP often have staff who can help verify your benefits and handle prior authorization.